LSE:GNS (Genus plc)

About GNS

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.
  • Genus plc (LSE: GNS) Latest News

    Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
    Page

    Investing in Genetics: Top UK Genetics Stocks in 2022

    Investing in genetics stocks is a risky endeavour. But given industry specialists have and continue to describe this space as…

    Read more »

    Investing Articles

    2 soaring small-cap growth stocks of 2020. Will their share prices fly in 2021?

    Many biotech and food companies fared well this year. Will these FTSE AIM All Share (INDEXFTSE: AXX) small-cap growth stocks…

    Read more »

    Investing Articles

    £1,000 to invest? I think buying this FTSE stock will make you money!

    Jabran Khan picks this FTSE 250 share as a great opportunity for you, especially on the back of impressive full-year…

    Read more »

    Investing Articles

    2 FTSE shares I’d buy in an ISA in April

    Here are two FTSE shares I think may be appropriate for a Stocks and Shares ISA when the annual allowance…

    Read more »

    Investing Articles

    These 2 FTSE 250 stocks are rising despite the crash. Here’s what I’d do now

    These two FTSE 250 growth stocks are climbing while markets plunge.

    Read more »

    Investing Articles

    Forget Bitcoin! I’d buy these undervalued FTSE 250 growth stocks today

    After recent falls, these FTSE 250 growth stocks look too cheap to pass up says this Fool.

    Read more »

    Investing Articles

    Why I think this FTSE 250 stock could trash the GSK share price

    I love GlaxoSmithKline plc (LON: GSK). But I reckon this FTSE 250 (INDEXFTSE: MCX) stock could beat it in the…

    Read more »

    Investing Articles

    Is the GSK share price primed to beat the FTSE 100?

    Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)?

    Read more »

    Investing Articles

    2 stunning growth stocks you might regret not buying

    Roland Head breaks down the latest numbers from two mid-cap growth stocks.

    Read more »

    Investing Articles

    Two growth stocks that could make you a millionaire

    These two shares offer a potent mix of growth and value potential.

    Read more »

    Investing Articles

    Why I’d buy Tristel plc and avoid Genus plc after HY results

    Half-year results reveal two different stories with Tristel plc (LON: TSTL) and Genus plc (LON: GNS)

    Read more »

    Investing Articles

    Why I’d buy this small-cap over Genus plc despite today’s positive results

    This smaller company has better growth prospects than Genus plc (LON: GNS).

    Read more »